Adalimumab Injection
Formulation (FDF) · Injection · 0.8ml: 40mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Adalimumab Injection
- Dosage Form
- Injection
- Strength
- 0.8ml: 40mg
- Therapy Area
- Immunology & Inflammation
- Indication
- Rheumatoid arthritis; Juvenile idiopathic arthritis; Ankylosing spondylitis; Psoriasis; Pediatric plaque psoriasis; Crohn's disease; Pediatric Crohn's disease; Uveitis
- Current Status
- Official FDF licensing catalog (UB651)
- GMP Certification
- CN - NMPA; PIC/S; SA - SFDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
ChinaSaudi Arabia
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price